89bio, Inc. - Common stock, par value $0.001 per share (ETNB)

Historical Holders from Q4 2019 to Q3 2025

Symbol
ETNB
Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
148,275,293
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
154,682,203
Holdings value
$2,273,597,098
% of all portfolios
0.01%
Number of holders
195
Number of buys
113
Number of sells
-103
Average buys %
+0.01%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Deep Track Capital, LP 6.31% -31.9% $137,535,714 -$65,564,381 9,356,171 -32.3% Deep Track Capital, LP 30 Sep 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 5.6% -43% $121,716,000 -$93,071,712 8,280,000 -43.3% SUVRETTA CAPITAL MANAGEMENT, LLC 30 Sep 2025
VANGUARD GROUP INC 5.64% $80,937,952 8,242,154 The Vanguard Group 30 Jun 2025
JANUS HENDERSON GROUP PLC 3.6% -75.7% $79,060,933 -$226,534,240 5,378,185 -74.1% JANUS HENDERSON GROUP PLC 30 Sep 2025
BIOTECHNOLOGY VALUE FUND L P 3.6% $29,903,806 4,333,885 BVF PARTNERS L P/IL 31 Dec 2024
RTW INVESTMENTS, LP 1.3% $13,575,936 1,967,527 RTW Investments, LP 31 Mar 2025

Institutional Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 154,682,203 $2,273,597,098 -$595,412 $14.70 195
2025 Q2 161,195,505 $1,583,221,092 +$87,329,463 $9.82 181
2025 Q1 154,244,684 $1,137,978,261 +$235,722,517 $7.27 184
2024 Q4 121,178,976 $947,691,955 +$128,680,752 $7.82 152
2024 Q3 104,404,540 $772,806,478 +$3,735,695 $7.40 142
2024 Q2 103,292,520 $827,294,025 +$24,658,190 $8.01 142
2024 Q1 98,362,601 $1,144,204,045 +$51,039,250 $11.64 147
2023 Q4 94,160,760 $1,051,783,052 +$196,443,321 $11.17 152
2023 Q3 71,959,726 $1,111,096,654 -$104,333,237 $15.44 159
2023 Q2 77,249,037 $1,463,933,277 +$131,611,867 $18.95 157
2023 Q1 70,992,649 $1,081,023,134 +$392,960,831 $15.23 146
2022 Q4 46,306,156 $589,465,858 +$135,450,817 $12.73 106
2022 Q3 39,211,413 $227,032,083 +$45,497,652 $5.79 84
2022 Q2 32,453,686 $104,561,000 +$48,026,442 $3.22 67
2022 Q1 17,066,227 $64,336,000 -$14,898,951 $3.77 65
2021 Q4 17,305,335 $226,115,000 -$710,006 $13.07 48
2021 Q3 17,322,134 $339,441,000 +$9,163,211 $19.59 47
2021 Q2 16,857,498 $315,233,000 -$5,578,791 $18.70 49
2021 Q1 16,916,139 $400,591,000 +$4,523,002 $23.68 67
2020 Q4 16,716,696 $407,455,000 +$14,912,147 $24.37 68
2020 Q3 16,031,339 $411,152,774 +$129,937,788 $25.66 68
2020 Q2 10,412,527 $207,490,000 -$1,581,200 $19.93 36
2020 Q1 10,699,602 $270,165,000 +$7,519,389 $25.25 30
2019 Q4 10,441,990 $274,521,000 +$272,245,001 $26.29 34